Petra Zoellner

Petra directs MedTech Europe’s team focusing on implementation of the EU regulatory systems for medical devices and in vitro diagnostic medical devices (IVDs). She represents MedTech Europe to external fora on strategic regulatory policy questions, including the Medical Devices Coordination Group. She acts as part of MedTech Europe’s leadership team, ensuring collaboration and coherence on topics which cross over to other areas in the medical technologies’ ecosystem. Petra also coordinates MedTech Europe’s Neuromodulation Sector Group, a business leaders group active in manufacturing devices for areas including brain health and pain management.

Since Petra joined the association (previously EDMA, now MedTech Europe) in February 2012, her work has included leading and representing the association on regulatory policy in various domains including on implementation of the MD Regulation and IVD Regulation, CE-marking topics, device labelling, trade in animal by-products, European database, medtech standards, and regulation of substances and electronic devices, amongst others.

Before MedTech Europe, Petra worked for the American Chamber of Commerce to the EU (AmCham EU), where she headed up the policy team working on both legislative and regulatory issues. She also worked within the government affairs team of Genzyme. As an American-German national raised in Denmark who has lived many years in Belgium, Petra is a native English speaker with various knowledge in Dutch, Danish, German and French.